# IRAK4-QSAR-Docking-ADMET-MD-MYD88L265P
Integrated QSAR, Docking, Pharmacokinetics, and Molecular Dynamics Approach for Designing IRAK4 Inhibitors Against MYD88^L265P-Driven Diffuse Large B-Cell Lymphoma
